Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hemostemix Inc (TSE:HEM)
TSXV:HEM
Hemostemix (HEM) Stock Price & Analysis
13 Followers
HEM Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.04 - C$0.18
Previous CloseC$0.05
Volume119.00K
Average Volume (3M)90.57K
Market Cap
C$3.92M
Enterprise ValueC$8.35M
Total Cash (Recent Filing)C$35.07K
Total Debt (Recent Filing)C$4.47M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Aug 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding87,122,318
10 Day Avg. Volume61,210
30 Day Avg. Volume90,571
Standard Deviation0.83
R-Squared0.00053
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)-0.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-13.20
P/FCF Ratio17.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hemostemix News
PremiumCompany Announcements
Hemostemix Accelerates Cell Therapy Production with CytoImmune
PremiumCompany Announcements
Hemostemix Partners with OHAM for Strategic Fundraising
HEM FAQ
What was Hemostemix Inc’s price range in the past 12 months?
Hemostemix Inc lowest stock price was C$0.04 and its highest was C$0.17 in the past 12 months.
What is Hemostemix Inc’s market cap?
Currently, no data Available
When is Hemostemix Inc’s upcoming earnings report date?
Hemostemix Inc’s upcoming earnings report date is Aug 26, 2024 which is in 33 days.
How were Hemostemix Inc’s earnings last quarter?
Currently, no data Available
Is Hemostemix Inc overvalued?
According to Wall Street analysts Hemostemix Inc’s price is currently Overvalued.
Does Hemostemix Inc pay dividends?
Hemostemix Inc does not currently pay dividends.
What is Hemostemix Inc’s EPS estimate?
Hemostemix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hemostemix Inc have?
Hemostemix Inc has 87,122,314 shares outstanding.
What happened to Hemostemix Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hemostemix Inc?
Currently, no hedge funds are holding shares in TSE:HEM
---
Hemostemix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.50%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-81.15%
Trailing 12-Months
Company Description
Hemostemix Inc
Hemostemix Inc is a Canada based clinical-stage biotechnology company. Its principal business activity is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.
---
Technical Analysis
---